Laboratory of Molecular Immuno-Oncology, Iloilo
Total core antigen assay is useful in diagnosing hepatitis C virus infection
Published in Lab Business Week, January 8th, 2006
"Hemodialysis patients are recognized as a group at high risk of infection with HCV. Therefore, such a population should be screened routinely for the presence of HCV viremia."
"Since nucleic acid techniques remain expensive and largely unavailable in many laboratories in the developing world, the present study assesses the clinical usefulness of the HCV core antigen enzyme immunoassay for the diagnosis of HCV infection in dialysis patients," wrote N. Bouzgarrou and colleagues, Laboratory of Molecular Immuno-Oncology.
"One...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-01-08)
More Articles from Lab Business Week
- 4SC AG
Prelisting capital increase successfully completed by arthritis drug developer - Aksys, Ltd.
Dialysis systems maker implements more focused strategy to reduce cash burn rate - Alexion Pharmaceuticals, Inc.
Hematologic-focused pharmaceutical firm posts loss of $1.16 per share - Allion Healthcare, Inc.
Allion Healthcare files registration statement for public offering of common stock - AnorMED, Inc.
Hematology-focused biotech firm exercises underwriters' option - Antisense Pharma
Cancer drug developer raises $18M in venture financing - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
